Viewing nowCombinationAetista Tablets 40/5 mg
Telmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Huons Life Science Co., Ltd.

MFDS item code 201700618 · Approved 2017.02.06 · Insurance code 052701050
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension is a common form of hypertension, where additional treatment is needed when blood pressure is not sufficiently controlled by either telmisartan or amlodipine monotherapy. In such cases, the combination of the two medications or consideration of other treatment options is employed to effectively lower blood pressure. This helps reduce the risk of cardiovascular complications and improves the patient's health status.
The recommended dose of this medicine is 1 tablet once daily, taken with water, regardless of meals. If possible, it is recommended to take it at the same time each day (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before treatment with this medicine; however, an immediate switch to this medicine may be considered if blood pressure is not controlled with the individual components, as follows. - 40/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or telmisartan 40 mg. - 80/5 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or this medicine 40/5 mg. - 40/10 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 mg). ○ Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. In patients with severe renal impairment, it is recommended to initiate treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan in patients with mild or moderate hepatic impairment should not exceed 40 mg. ◦ Elderly patients: The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring caution when taking this medicine’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, initiate treatment at a low dose and increase the dose gradually.
○ Children: Use of this medicine is not recommended in pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This medication can cause severe harm to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be used by pregnant women or women who may become pregnant. This medication should not be administered to patients with hypersensitivity to the active ingredients, biliary obstruction diseases, severe liver disease, or significant cardiac disorders. In patients with impaired kidney function, or those with moderate to severe kidney impairment among diabetic patients, the combination of this medication and certain drugs is prohibited. Caution is advised for patients with primary aldosteronism, cardiac valve diseases, liver disorders, gastrointestinal diseases, renal vascular hypertension, those undergoing dialysis for renal failure, and the elderly. Common side effects of this medication may include dizziness, peripheral edema, and others, and serious adverse reactions have been reported rarely, so immediate consultation with a physician is required if unusual symptoms occur. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be stopped immediately and alternative therapies should be initiated. It is also recommended that lactating women do not use this medication and consult a physician if they are breastfeeding. Patients with fluid or salt depletion should be particularly cautious as symptoms of hypotension may occur due to low blood pressure. Blood potassium levels may increase, so patients at risk for hyperkalemia should have regular blood tests done. Patients with impaired kidney function should undergo regular kidney function tests before and during treatment with this medication. Interactions may occur when this medication is used with other antihypertensive agents or certain drugs, so it is essential to inform the doctor or pharmacist of any other medications being taken. Dizziness or drowsiness may occur while driving or operating machinery, so caution is necessary. In case of overdose, serious hypotension or cardiac issues may occur, thus it is crucial to adhere to the prescribed dose and visit a medical institution immediately if unusual symptoms arise. Keep this medication out of the reach of children, store it in its original packaging, and it is advisable to take it immediately after opening.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in a container that prevents light exposure. Additionally, it is important to store it at room temperature, specifically between 1 to 30 degrees Celsius, to maintain its effectiveness.
Biconvex oval double-coated tablet in white and pale blue
30 tablets/box (10 tablets/Alu-Alu X3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Huons Life Science Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.